AzTrials
AzTrials

Acute Kidney InjuryNCT05409690

Renal Arterial Resistive Index for Differential Diagnosis of Acute Kidney Injury

An observational study of Acute Kidney Injury, run by Ankara Diskapi Training and Research Hospital at 1 site in Turkey (Türkiye).

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

early differential diagnosis of anticipated acute kidney injury via ultrasound renal resistive index calculation Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Acute Kidney Injury
How many people
30 participants
Where
1 siteTurkey (Türkiye)
Study dates
10 May 2022to 10 Nov 2022
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: patient administering to emergency service with acute kidney injury independent of etiology

Who may be able to join

  • age over 18
  • patient with acute kidney injury diagnosed according to KDIGO, AKIN or RIFLE criteria

Who cannot join

  • end stage kidney disease
  • patients receiving renal replacement treatment

Trial locations and contacts

1 site in 1 country.

bedriye müge sönmez, assoc. prof. contact

00905055823208

mugesonmez06@yahoo.com

gülşen çığşar, assoc. prof. contact

00905052874949

gulakcay@yahoo.com

Turkey (Türkiye)1 site, 1 recruiting
  • Diskapi Research and Training Hospital

    Ankara, 06110

    bedriye müge sönmez, assoc. prof, +905055823208, mugesonmez06@yahoo.com

    bedriye müge sönmez, assoc. prof

    Recruiting

Other trials in Turkey (Türkiye)

About this study

Official title: Value of Renal Resistive Arterial Index for Differential Diagnosis of Patient With Anticipated Acute Kidney Injury Administered to Emergency Department

early differential diagnosis of anticipated acute kidney injury via ultrasound renal resistive index calculation

Read the detailed description

acute kidney injury is a common clinical syndrome introducing to emergency services with varying symptoms. acute kidney injury is divided into 3 subgroups: prerenal, renal and postrenal. there is not any certain laboratory or imaging modality for early detection of injury's type. calculation of renal resistive index with doppler ultrasound at emergency setting can be helpful for early detection of etiology of acute kidney injury subgroup.patient will be selected according to clinical status and detailed history and laboratory parameters.renal resistive index will we calculated with doppler ultrasound of arcuate and interlober arteries of kidneys. resistive index values of acute kidney injury patients will be compared depending on further tests and resistive indexes of suggestive etiologies will be compared according to final diagnosis.

Keywords
acute kidney injury, renal resistive index, doppler ultrasound
Medical subject headings
Acute Kidney Injury

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. increased resistive index

    differential diagnosis of acute kidney injury using renal doppler ultrasound and resistive index and comparison of subgroups

    Measured: time spent at emergency service until renal doppler is done and resisitive index is calculated (6 hours)

Secondary outcomes (2)
  1. mortality

    mortality

    Measured: mortality at 7 days

  2. mortality

    mortality

    Measured: mortality at 28 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Jun 2022
  2. Study start10 May 2022
  3. Primary completion10 Nov 2022 (estimated)
  4. Study completion10 Nov 2022 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
30 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05409690
Sponsor's protocol ID
AnkaraDiskapiTRHAKI
Status last verified
Jun 2022
First submitted
4 Jun 2022
Last updated
8 Jun 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Acute Kidney Injury, run by Ankara Diskapi Training and Research Hospital at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 8 Jun 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact bedriye müge sönmez, assoc. prof. (00905055823208, mugesonmez06@yahoo.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

increased resistive index (time frame: time spent at emergency service until renal doppler is done and resisitive index is calculated (6 hours)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Jun 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in